Stuttering Therapeutics Market Projected to Gain Significant Value through 2033
The global Stuttering Therapeutics Market is estimated to generate a market value of US$ 43 Million in 2023 and a market value of US$ 159.41 Million by 2033, with a CAGR of 14% from 2023 to 2033. In the historical period 2018 to 2022, the market for Stuttering Therapeutics grew at a CAGR of 11%. The market for stuttering therapeutics refers to pharmaceuticals, therapies, and devices used to treat stuttering, a speech disorder characterised by involuntary repetitions or prolongations of sounds, syllables, or phrases, as well as pauses or blocks in speech. The global stuttering therapeutics market is predicted to expand significantly in the future years, owing to increased awareness of the illness, an expanding patient population, and breakthroughs in research and development of new treatments. Several treatments for stuttering are currently accessible, including antipsychotics, antidepressants, and anticonvulsants. These drugs, however, have not been specifically authorised by the FDA ...